Bionano Genomics Inc expected to post a loss of 10 cents a share - Earnings Preview

Reuters

Jul 31, 2023

* Bionano Genomics Inc is expected to show a rise in quarterly revenue when it reports results on August 2 (estimated).

* The San Diego California-based company is expected to report a 24.4% increase in revenue to $8.295 million from $6.67 million a year ago, according to the mean estimate from 5 analysts, based on Refinitiv data. The company's guidance on May 9 2023, for the period ended June 30, was for revenue between $7.80 million and $8.30 million.

* Refinitiv's mean analyst estimate for Bionano Genomics Inc is for a loss of 10 cents per share.

* The current average analyst rating on the shares is "strong buy" and the breakdown of recommendations is 5 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."

* The mean earnings estimate of analysts was unchanged in the last three months.

* Wall Street's median 12-month price target for Bionano Genomics Inc is $3, above its last closing price of $0.58.

Previous quarterly performance (using preferred earnings measure in US dollars).

QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI

ENDING ARTESTIMAT IBES MET, SE %

E® ESTIMATE MISSED

Mar. 31 2023 -0.11 -0.11 -0.12 Missed -9.1

Dec. 31 2023 -0.11 -0.11 -0.13 Missed -18.2

Sep. 30 2022 -0.12 -0.11 -0.11 Met 4.3

Jun. 30 2022 -0.10 -0.09 -0.11 Missed -20.4

Mar. -0.09 -0.07 -0.11 Missed -46.7

31 2022

Dec. 31 2021 -0.06 -0.06 -0.08 Missed -23.6

Sep. 30 2021 -0.06 -0.06 -0.07 Missed -30.6

Jun. 30 2021 -0.05 -0.05 -0.06 Missed -32.6

This summary was machine generated July 31 at 13:24 GMT. All figures in US dollars unless otherwise stated.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2355803049"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2355803049\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2355803049?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2023-07-31 21:24","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2355803049","market":"us","top_or_hot":-1,"title":"Bionano Genomics Inc expected to post a loss of 10 cents a share - Earnings Preview","media":"Reuters","content":"<html><body><p>* <a href=\"https://laohu8.com/S/BNGOW\">Bionano Genomics Inc</a>     is expected to show a rise in quarterly revenue when it reports  results on August 2 (estimated). </p><p>   * The San Diego California-based  company is expected to report  a 24.4% increase in revenue to $8.295 million from $6.67 million a year ago, according to the mean estimate from 5 analysts, based on Refinitiv data. The company's guidance on May 9 2023, for the period ended June 30, was for revenue between $7.80 million and $8.30 million.</p><p>   * Refinitiv's mean analyst estimate for <a href=\"https://laohu8.com/S/BNGO\">Bionano Genomics</a> Inc is for a loss of 10 cents per share. </p><p>   * The current average analyst rating on the shares is \"strong buy\" and the breakdown of recommendations is 5 \"strong buy\" or \"buy,\" no \"hold\" and no \"sell\" or \"strong sell.\"  </p><p>   * The mean earnings estimate of analysts was unchanged in the last three months. </p><p>   * Wall Street's median 12-month price target for Bionano Genomics Inc is $3, above its last closing price of $0.58. </p><p>Previous quarterly performance (using preferred earnings measure in US dollars). </p><p>QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI</p><p>ENDING        ARTESTIMAT  IBES                 MET,    SE %</p><p>              E®          ESTIMATE             MISSED  </p><p>Mar. 31 2023  -0.11       -0.11      -0.12     Missed  -9.1</p><p>Dec. 31 2023  -0.11       -0.11      -0.13     Missed  -18.2</p><p>Sep. 30 2022  -0.12       -0.11      -0.11     Met     4.3</p><p>Jun. 30 2022  -0.10       -0.09      -0.11     Missed  -20.4</p><p>Mar.        -0.09       -0.07      -0.11     Missed  -46.7</p><p>31 2022                                                </p><p>Dec. 31 2021  -0.06       -0.06      -0.08     Missed  -23.6</p><p>Sep. 30 2021  -0.06       -0.06      -0.07     Missed  -30.6</p><p>Jun. 30 2021  -0.05       -0.05      -0.06     Missed  -32.6</p><p>This summary was machine generated July 31 at 13:24 GMT.  All figures in US dollars  unless otherwise stated.</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Bionano Genomics Inc expected to post a loss of 10 cents a share - Earnings Preview</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBionano Genomics Inc expected to post a loss of 10 cents a share - Earnings Preview\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2023-07-31 21:24</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p>* <a href=\"https://laohu8.com/S/BNGOW\">Bionano Genomics Inc</a>     is expected to show a rise in quarterly revenue when it reports  results on August 2 (estimated). </p><p>   * The San Diego California-based  company is expected to report  a 24.4% increase in revenue to $8.295 million from $6.67 million a year ago, according to the mean estimate from 5 analysts, based on Refinitiv data. The company's guidance on May 9 2023, for the period ended June 30, was for revenue between $7.80 million and $8.30 million.</p><p>   * Refinitiv's mean analyst estimate for <a href=\"https://laohu8.com/S/BNGO\">Bionano Genomics</a> Inc is for a loss of 10 cents per share. </p><p>   * The current average analyst rating on the shares is \"strong buy\" and the breakdown of recommendations is 5 \"strong buy\" or \"buy,\" no \"hold\" and no \"sell\" or \"strong sell.\"  </p><p>   * The mean earnings estimate of analysts was unchanged in the last three months. </p><p>   * Wall Street's median 12-month price target for Bionano Genomics Inc is $3, above its last closing price of $0.58. </p><p>Previous quarterly performance (using preferred earnings measure in US dollars). </p><p>QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI</p><p>ENDING        ARTESTIMAT  IBES                 MET,    SE %</p><p>              E®          ESTIMATE             MISSED  </p><p>Mar. 31 2023  -0.11       -0.11      -0.12     Missed  -9.1</p><p>Dec. 31 2023  -0.11       -0.11      -0.13     Missed  -18.2</p><p>Sep. 30 2022  -0.12       -0.11      -0.11     Met     4.3</p><p>Jun. 30 2022  -0.10       -0.09      -0.11     Missed  -20.4</p><p>Mar.        -0.09       -0.07      -0.11     Missed  -46.7</p><p>31 2022                                                </p><p>Dec. 31 2021  -0.06       -0.06      -0.08     Missed  -23.6</p><p>Sep. 30 2021  -0.06       -0.06      -0.07     Missed  -30.6</p><p>Jun. 30 2021  -0.05       -0.05      -0.06     Missed  -32.6</p><p>This summary was machine generated July 31 at 13:24 GMT.  All figures in US dollars  unless otherwise stated.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BNGOW","symbol_name":"Bionano Genomics Inc","start_time":0,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","article_id":"2355803049","we_media_id":"1036604489","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2355803049","pubTimestamp":1690809874,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"summary":"* Bionano Genomics Inc     is expected to show a rise in quarterly revenue when it reports  results on August 2 (estimated).    * The San Diego California-based  company is expected to report  a 24.4%","collect":0,"end_time":0,"defaultTopTitle":"","property":["earning"],"viewcount":null,"language":"en","relate_stocks":{"BNGOW":"Bionano Genomics Inc","BNGO":"Bionano Genomics"},"translate_title":"Bionano Genomics公司预计每股亏损10美分","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"BNGOW":1,"BNGO":0.9},"content_text":"* Bionano Genomics Inc     is expected to show a rise in quarterly revenue when it reports  results on August 2 (estimated).    * The San Diego California-based  company is expected to report  a 24.4% increase in revenue to $8.295 million from $6.67 million a year ago, according to the mean estimate from 5 analysts, based on Refinitiv data. The company's guidance on May 9 2023, for the period ended June 30, was for revenue between $7.80 million and $8.30 million.   * Refinitiv's mean analyst estimate for Bionano Genomics Inc is for a loss of 10 cents per share.    * The current average analyst rating on the shares is \"strong buy\" and the breakdown of recommendations is 5 \"strong buy\" or \"buy,\" no \"hold\" and no \"sell\" or \"strong sell.\"     * The mean earnings estimate of analysts was unchanged in the last three months.    * Wall Street's median 12-month price target for Bionano Genomics Inc is $3, above its last closing price of $0.58. Previous quarterly performance (using preferred earnings measure in US dollars). QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRIENDING        ARTESTIMAT  IBES                 MET,    SE %              E®          ESTIMATE             MISSED  Mar. 31 2023  -0.11       -0.11      -0.12     Missed  -9.1Dec. 31 2023  -0.11       -0.11      -0.13     Missed  -18.2Sep. 30 2022  -0.12       -0.11      -0.11     Met     4.3Jun. 30 2022  -0.10       -0.09      -0.11     Missed  -20.4Mar.        -0.09       -0.07      -0.11     Missed  -46.731 2022                                                Dec. 31 2021  -0.06       -0.06      -0.08     Missed  -23.6Sep. 30 2021  -0.06       -0.06      -0.07     Missed  -30.6Jun. 30 2021  -0.05       -0.05      -0.06     Missed  -32.6This summary was machine generated July 31 at 13:24 GMT.  All figures in US dollars  unless otherwise stated.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}